loader

clinical stage immuno-oncology company

LATEST ARTICLES

Surface Oncology Announces $119.5 Million Aggregate Financing

New Preclinical Studies Reinforce the Potential for Heightened Anti-Cancer Activity of Combination Therapies Based on Immunovaccine’s Proprietary Delivery Platform

Trillium Therapeutics Provides Update on Its TTI-621 and TTI-622 Clinical Programs

Immunovaccine Announces Initiation of Patient Dosing in Investigator-Sponsored Phase 2 Clinical Trial

Trillium Therapeutics Reports Annual 2017 Financial and Operating Results

Helix BioPharma Appoints Deloitte as Strategic Advisor to Explore Partnering and Licensing Opportunities

Merus Announces $55.8 Million Private Placement Offering of Common Stock

Published Study Demonstrates the Association Between Immunovaccine’s Proprietary Immune-targeted Delivery Technology

Merus Announces First Patient Dosed in a Phase 2 Clinical Trial of MCLA-128 in Two Metastatic Breast Cancer Patient Populations

pharmaceutical investing

Immunovaccine Shows Preclinical Research At Cancer Meeting

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES